Avalo Therapeutics (STU:C6K0) Long-Term Debt : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Avalo Therapeutics Long-Term Debt?

Avalo Therapeutics's Long-Term Debt for the quarter that ended in Mar. 2024 was €0.00 Mil.

Avalo Therapeutics's annual Long-Term Debt declined from Dec. 2021 (€29.06 Mil) to Dec. 2022 (€12.73 Mil) and declined from Dec. 2022 (€12.73 Mil) to Dec. 2023 (€0.00 Mil).

Avalo Therapeutics Long-Term Debt Historical Data

The historical data trend for Avalo Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalo Therapeutics Long-Term Debt Chart

Avalo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

29.06

12.73

Avalo Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															9.78	-	-	-	-

Avalo Therapeutics (STU:C6K0) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Avalo Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Avalo Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Avalo Therapeutics (STU:C6K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (STU:C6K0) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

AVTX:USA C6K0:Germany

Address

540 Gaither Road, Suite 400, Rockville, MD, USA, 20850

Website

https://www.avalotx.com

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Avalo Therapeutics (STU:C6K0) Headlines

No Headlines